Skip to main content

Advertisement

SpringerLink
Log in

Intake and circulating concentrations of antioxidants in metabolic syndrome

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Metabolic syndrome, which occurs commonly in populations around the world, has been associated with an increased risk for developing cardiovascular disease and diabetes. Oxidative stress, which has been implicated in the pathogenesis of cardiovascular disease and diabetes, is a common feature of metabolic syndrome. Limited evidence suggests that circulating concentrations of antioxidants are decreased among people with metabolic syndrome. The contributions of reduced consumption and increased utilization of antioxidants leading to increased oxidative stress are largely unknown. People with metabolic syndrome appear to be an attractive group for future research about possible therapeutic options of antioxidants in the medical management of this syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28:2745–2749.

    Article  PubMed  Google Scholar 

  2. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769–1778.

    Article  PubMed  Google Scholar 

  3. Lee KU: Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001, 54(Suppl 2):S29-S33.

    Article  PubMed  CAS  Google Scholar 

  4. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003, 108:2034–2040.

    Article  PubMed  Google Scholar 

  5. Stephens JW, Gable DR, Hurel SJ, et al.: Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006, 52:446–452.

    Article  PubMed  CAS  Google Scholar 

  6. Knekt P, Ritz J, Pereira MA, et al.: Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004, 80:1508–1520.

    PubMed  CAS  Google Scholar 

  7. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405–412.

    Article  PubMed  CAS  Google Scholar 

  8. Ford ES, Will JC, Bowman BA, Narayan KM: Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999, 149:168–176.

    PubMed  CAS  Google Scholar 

  9. Salonen JT, Nyyssonen K, Tuomainen TP, et al.: Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 1995, 311:1124–1127.

    PubMed  CAS  Google Scholar 

  10. Knekt P, Reunanen A, Marniemi J, et al.: Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 1999, 245:99–102.

    Article  PubMed  CAS  Google Scholar 

  11. Mayer-Davis EJ, Costacou T, King I, et al.: Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 2002, 25:2172–2177.

    Article  PubMed  CAS  Google Scholar 

  12. Hozawa A, Jacobs DR Jr, Steffes MW, et al.: Associations of Serum Carotenoid Concentrations with the Development of Diabetes and with Insulin Concentration: Interaction with Smoking: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006, 163:929–937.

    Article  PubMed  Google Scholar 

  13. Montonen J, Knekt P, Jarvinen R, Reunanen A: Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27:362–366.

    Article  PubMed  CAS  Google Scholar 

  14. Liu S, Ajani U, Chae C, et al.: Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999, 282:1073–1075.

    Article  PubMed  CAS  Google Scholar 

  15. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al.: Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004, 147:106–112.

    Article  PubMed  Google Scholar 

  16. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al.: The adoption of Mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndrome. Nutr J 2003, 2:1.

    Article  PubMed  Google Scholar 

  17. Esposito K, Marfella R, Ciotola M, et al.: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440–1446.

    Article  PubMed  CAS  Google Scholar 

  18. Ford ES, Mokdad AH, Giles WH, Brown DW: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003, 52:2346–2352.

    Article  PubMed  CAS  Google Scholar 

  19. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.

    Article  PubMed  CAS  Google Scholar 

  20. Evans JL, Maddux BA, Goldfine ID: The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005, 7:1040–1052.

    Article  PubMed  CAS  Google Scholar 

  21. Facchini FS, Humphreys MH, DoNascimento CA, et al.: Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr 2000, 72:776–779.

    PubMed  CAS  Google Scholar 

  22. Ylonen K, Alfthan G, Groop L, et al.: Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. Am J Clin Nutr 2003, 77:1434–1441.

    PubMed  Google Scholar 

  23. Coyne T, Ibiebele TI, Baade PD, et al.: Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005, 82:685–693.

    PubMed  CAS  Google Scholar 

  24. Ford ES, Mokdad AH, Ajani UA, Liu S: Associations between concentrations of alpha- and gamma-tocopherol and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide among US adults. Br J Nutr 2005, 93:249–255.

    Article  PubMed  CAS  Google Scholar 

  25. Sugiura M, Nakamura M, Ikoma Y, et al.: The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 2006, 16:71–78.

    Article  PubMed  Google Scholar 

  26. Paolisso G, D’Amore A, Giugliano D, et al.: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993, 57:650–656.

    PubMed  CAS  Google Scholar 

  27. Paolisso G, D’Amore A, Galzerano D, et al.: Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993, 16:1433–1437.

    Article  PubMed  CAS  Google Scholar 

  28. Paolisso G, Di Maro G, Galzerano D, et al.: Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994, 59:1291–1296.

    PubMed  CAS  Google Scholar 

  29. Skrha J, Sindelka G, Kvasnicka J, Hilgertova J: Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus. Diabetes Res Clin Pract 1999, 44:27–33.

    Article  PubMed  CAS  Google Scholar 

  30. Manning PJ, Sutherland WH, Walker RJ, et al.: Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004, 27:2166–2171.

    Article  PubMed  CAS  Google Scholar 

  31. McSorley PT, Bell PM, Young IS, et al.: Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med 2005, 22:703–710.

    Article  PubMed  CAS  Google Scholar 

  32. Johnston CS, Yen MF: Megadose of vitamin C delays insulin response to a glucose challenge in normoglycemic adults. Am J Clin Nutr 1994, 60:735–738.

    PubMed  CAS  Google Scholar 

  33. Paolisso G, Balbi V, Volpe C, et al.: Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995, 14:387–392.

    PubMed  CAS  Google Scholar 

  34. Chen H, Karne RJ, Hall G, et al.: High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006, 290:H137–145.

    Article  PubMed  CAS  Google Scholar 

  35. Fornoni A, Raij L: Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep 2005, 7:88–95.

    PubMed  CAS  Google Scholar 

  36. Duvall WL: Endothelial dysfunction and antioxidants. Mt Sinai J Med 2005, 72:71–80.

    PubMed  Google Scholar 

  37. Sola S, Mir MQ, Cheema FA, et al.: Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005, 111:343–348.

    Article  PubMed  CAS  Google Scholar 

  38. Ford ES: The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168:351–358.

    Article  PubMed  CAS  Google Scholar 

  39. Cannon JG, Meydani SN, Fielding RA, et al.: Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis. Am J Physiol 1991, 260(6 Pt 2):R1235–1240.

    PubMed  CAS  Google Scholar 

  40. Devaraj S, Jialal I: Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 2000, 29:790–792.

    Article  PubMed  CAS  Google Scholar 

  41. Murphy RT, Foley JB, Tome MT, et al.: Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes. Free Radic Biol Med 2004, 36:959–965.

    Article  PubMed  CAS  Google Scholar 

  42. Wu D, Han SN, Meydani M, Meydani SN: Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N Y Acad Sci 2004, 1031:422–424.

    Article  PubMed  Google Scholar 

  43. Kaul N, Devaraj S, Grundy SM, Jialal I: Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects. Am J Cardiol 2001, 87:1320–1323.

    Article  PubMed  CAS  Google Scholar 

  44. Vega-Lopez S, Kaul N, Devaraj S, et al.: Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004, 53:236–240.

    Article  PubMed  CAS  Google Scholar 

  45. Carr BR, Khan N, Adams-Huet B, et al.: Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women. Fertil Steril 2006, 85:667–673.

    Article  PubMed  CAS  Google Scholar 

  46. Block G, Jensen C, Dietrich M, et al.: Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 2004, 23:141–147.

    PubMed  CAS  Google Scholar 

  47. Tousoulis D, Antoniades C, Tentolouris C, et al.: Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003, 170:261–267.

    Article  PubMed  CAS  Google Scholar 

  48. Scott DA, Poston RN, Wilson RF, et al.: The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers. Inflamm Res 2005, 54:138–144.

    Article  PubMed  CAS  Google Scholar 

  49. Fumeron C, Nguyen-Khoa T, Saltiel C, et al.: Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005, 20:1874–1879.

    Article  PubMed  CAS  Google Scholar 

  50. Carroll MF, Schade DS: Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003, 108:24–31.

    Article  PubMed  CAS  Google Scholar 

  51. Engler MM, Engler MB, Malloy MJ, et al.: Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003, 108:1059–1063.

    Article  PubMed  CAS  Google Scholar 

  52. Phillips T, Childs AC, Dreon DM, et al.: A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males. Med Sci Sports Exerc 2003, 35:2032–2037.

    Article  PubMed  CAS  Google Scholar 

  53. Accinni R, Rosina M, Bamonti F, et al.: Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 2006, 16:121–127.

    Article  PubMed  CAS  Google Scholar 

  54. Mastaloudis A, Morrow JD, Hopkins DW, et al.: Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004, 36:1329–1341.

    Article  PubMed  CAS  Google Scholar 

  55. Watzl B, Kulling SE, Moseneder J, et al.: A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 2005, 82:1052–1058.

    PubMed  CAS  Google Scholar 

  56. de Maat MP, Pijl H, Kluft C, Princen HM: Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr 2000, 54:757–763.

    Article  PubMed  Google Scholar 

  57. Riso P, Visioli F, Grande S, et al.: Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J Agric Food Chem 2006, 54:2563–2566.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centers for Disease Control and Prevention, 4770 Buford Highway, MS K66, 30341, Atlanta, GA, USA

    Earl S. Ford MD, MPH

Authors
  1. Earl S. Ford MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Earl S. Ford MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ford, E.S. Intake and circulating concentrations of antioxidants in metabolic syndrome. Curr Atheroscler Rep 8, 448–452 (2006). https://doi.org/10.1007/s11883-006-0018-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-006-0018-8

Keywords

Search

Navigation